Sarah Cannon Cancer Institute at HealthONE — Denver, Colorado

Sarah Cannon Cancer Institute at HealthONE is a clinical research site located in Denver, Colorado, United States 80218.

Crixeo Clinical Trials Trust Score: 11/100 (FAILING). This profile has not yet been claimed by the site owner.

Sarah Cannon Cancer Institute at HealthONE has participated in 2 clinical trials with 2 currently active.

Therapeutic areas: KRAS G12C Mutation, KRAS G12S Mutation, Solid Tumor Malignancies.

Sponsors: Kumquat Biosciences Inc..

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Denver

Browse all research sites in Colorado · View every site in Denver

Sponsor Feasibility Report

Trust Score: 11/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Sarah Cannon Cancer Institute at HealthONE?

Sarah Cannon Cancer Institute at HealthONE has a Crixeo Trust Score of 11/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Sarah Cannon Cancer Institute at HealthONE conducted?

Sarah Cannon Cancer Institute at HealthONE has 2 clinical trials on record, with 2 currently active. Their work covers KRAS G12C Mutation, KRAS G12S Mutation, Solid Tumor Malignancies.

Is Sarah Cannon Cancer Institute at HealthONE accredited by Crixeo Clinical Trials?

Sarah Cannon Cancer Institute at HealthONE has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Sarah Cannon Cancer Institute at HealthONE?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.